durvalumab
astrazeneca
['caspian', 'biotec']
 we will discuss astum005, the first pd1 mab/chemo combo international randomized ph3 trial that hit os hr of 0.63, compared the current soc impowe133 s 0.70 and caspian of 0.73. #indatawetrust #asco2022
A biotech junky and biz executive with permanent head damage (a.k.a Ph.D.). Tweets and opinions are my own. #InScienceWeTrust, #InDataWeTrust